600771.SS
600771.SS
CNE000000MY1
GUANGYUYUAN CHINESE HERBAL MEDI
Loading chart...

Company Profile

GuangYuYuan Chinese Herbal Medicine Co., Ltd. manufactures and sells Chinese medicinal products. The company offers traditional Chinese medicine, fine Chinese medicine, and health wine. It provides its products in the form of pills, powders, tablets, hard capsules, granules, compound preparations, and medicated eight dosage forms. The company was formerly known as Topsun Science And Technology Co Ltd. and changed its name to GuangYuYuan Chinese Herbal Medicine Co., Ltd. in July 2013. GuangYuYuan Chinese Herbal Medicine Co., Ltd. was founded in 1996 and is headquartered in Taiyuan, China.

Related stocks

600713.SS
600713.SS • China
NANJING PHARMACEUTICAL GP CO LT
5.14 CNY
1.01B USD 1Y +3.6%
300181.SZ
300181.SZ • China
ZUO LI YAO YE
13.25 CNY
1.39B USD 1Y -25.8%
300357.SZ
300357.SZ • China
WOLWO PHARMA
19.99 CNY
1.57B USD 1Y -30.7%
002019.SZ
002019.SZ • China
YIFAN PHARM
9.66 CNY
1.76B USD 1Y -30.7%
SANOFICONR.NS
SANOFICONR.NS • India
SANOFI CONS HEALTHC IND L
3,581.7 INR
853.55M USD 1Y -24.8%
SANOFI.BO
SANOFI.BO • India
SANOFI INDIA LTD
2,945.55 INR
700.95M USD 1Y -37%
PFIZER.NS
PFIZER.NS • India
PFIZER LTD
3,808.2 INR
1.8B USD 1Y -27.7%
RUBICON.NS
RUBICON.NS • India
RUBICON RESEARCH LIMITED
1,548.5 INR
2.65B USD

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
37.8% p.a.
Max Drawdown (5Y)
-70.8%
Sharpe Ratio (5Y)
-0.41
Beta Factor
0.28
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 High valuation risk: Avg P/E of 102.7 (Elevated multiple compression risk)
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (37.8% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -76.2% in the extended horizon.
ende